Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Matino

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2026
Evaluation of the Burden of Bone Fractures in People Living With Haemophilia: A Registry-Based Matched Cohort StudyFederico Germini, Arun Keepanasseril, Quazi Ibrahim, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 16, 2020
Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control StudyOwais Mian, Davide Matino, Robin Roberts, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 26, 2026
Perioperative Outcomes in Factor XI Deficiency: A Systematic ReviewZainab Al-Housni, Raeesah Mohammed, Silvio Ligia, et al.
Journal of Chemical Information and Modeling|November 18, 2014
Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR)Roberto Nuti, Marco Gargaro, Davide Matino, et al.
Scientific Reports|November 23, 2022
Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A miceSajjad Afraz, Ivan Stevic, Davide Matino, et al.
Autoimmunity Reviews|February 25, 2019
Amino acid metabolism as drug target in autoimmune diseasesGiada Mondanelli, Alberta Iacono, Agostinho Carvalho, et al.
Journal of Thrombosis and Haemostasis : JTH|May 10, 2026
Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS studyJohnny Mahlangu, Davide Matino, Olga Benitez Hidalgo, et al.
Blood|December 6, 2025
Efficacy and Safety of Marstacimab Prophylaxis in Hemophilia A/B With Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Suchitra Acharya, Carrie Turich Taylor, et al.
Therapeutic Advances in Hematology|June 18, 2026
A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimabDavide Matino, Suchitra S Acharya, Carrie Turich Taylor, et al.
Research and Practice in Thrombosis and Haemostasis|April 4, 2024
Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderRealCihan Ay, Olga Benitez-Hidalgo, Gillian Gidley, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2026
Evaluation of the Burden of Bone Fractures in People Living With Haemophilia: A Registry-Based Matched Cohort StudyFederico Germini, Arun Keepanasseril, Quazi Ibrahim, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 16, 2020
Potential Risk Factors Contributing to Development of Venous Thromboembolism for Total Knee Replacements Patients Prophylaxed With Rivaroxaban: A Retrospective Case-Control StudyOwais Mian, Davide Matino, Robin Roberts, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 26, 2026
Perioperative Outcomes in Factor XI Deficiency: A Systematic ReviewZainab Al-Housni, Raeesah Mohammed, Silvio Ligia, et al.
Journal of Chemical Information and Modeling|November 18, 2014
Ligand binding and functional selectivity of L-tryptophan metabolites at the mouse aryl hydrocarbon receptor (mAhR)Roberto Nuti, Marco Gargaro, Davide Matino, et al.
Scientific Reports|November 23, 2022
Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A miceSajjad Afraz, Ivan Stevic, Davide Matino, et al.
Autoimmunity Reviews|February 25, 2019
Amino acid metabolism as drug target in autoimmune diseasesGiada Mondanelli, Alberta Iacono, Agostinho Carvalho, et al.
Journal of Thrombosis and Haemostasis : JTH|May 10, 2026
Management of breakthrough bleeds and surgical procedures in participants with hemophilia A or B without inhibitors receiving marstacimab prophylaxis in the phase 3 BASIS studyJohnny Mahlangu, Davide Matino, Olga Benitez Hidalgo, et al.
Blood|December 6, 2025
Efficacy and Safety of Marstacimab Prophylaxis in Hemophilia A/B With Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Suchitra Acharya, Carrie Turich Taylor, et al.
Therapeutic Advances in Hematology|June 18, 2026
A plain language summary of the BASIS study looking at people living with severe hemophilia A or B with inhibitors and being treated with marstacimabDavide Matino, Suchitra S Acharya, Carrie Turich Taylor, et al.
Research and Practice in Thrombosis and Haemostasis|April 4, 2024
Noninterventional study assessing joint health in persons with hemophilia A after switching to turoctocog alfa pegol: design of pathfinderRealCihan Ay, Olga Benitez-Hidalgo, Gillian Gidley, et al.
Pageof 7